CCN4 and breast cancer: Firstly, the breast cancer susceptibility gene (BRCA) analysis in GEPIA was utilized to determine whether WISP1 is abnormally expressed in breast cancer, and it could be concluded that the expression of WISP1 was markedly elevated in breast cancer tissues in comparison with that in normal tissues (p< 0.05, Figure 1a).